Co-auteurs

Nom des revues

Nombre de documents

48

Laurent Laforest


1.1.      Parcours  

 

1986-1992: Etudes médicales  (PCEM Marseille; DCEM Paris Necker)

1993-1994: Résidanat Médecine Générale (Broussais; Beaumont sur Oise)

1993 : Concours d’Internat, poste en Santé Publique

1994-1999: Internat de Santé Publique (Tours et Paris), dont stage à l’Unité INSERM U88 (Pr Goldberg)

1998 : Thèse de Médecine soutenue en 1998 (Faculté de Tours)

 

2001 : Centre International de Recherche sur le Cancer (Lyon)

 

De 2001 à septembre 2017: Unité de Pharmacoépidémiologie de Lyon

 

Depuis septembre 2017 : MCU associé Faculté d’Odontologie

 

1.2.      Diplômes

 

1993 : Concours d’Internat en Médecine, poste en Santé Publique

1995 : DESS de Santé environnement (Saint-Maurice)

1997 : DEA de Santé Publique, option épidémiologie, Paris XI (D. Hémon). 

1998 : Thèse de Médecine soutenue en 1998 (Faculté de Tours)

2005 : Doctorat en Science (PhD) soutenue à Lyon en septembre 2005 (Université Claude Bernard)

 

1.3.      Compétences en anglais

 

Formations:

        First Certificate in English (grade B), University of Cambridge  (1993)

        Institut Langue.com, Lyon (72 heures). Baron test : 880/990 (2000)

        Wall Street Institute (2002-2004)

        E. Clerc School, Lyon (2008) :  TOEIC (925 points)

Utilisation quasi-quotidienne de l’anglais pour la dissémination des résultats et dans les projets de recherche internationaux.


Article dans une revue48 documents

  • Denis Bourgeois, Ina Saliasi, Claude Dussard, Juan Llodra, Delphine Tardivo, et al.. Educational outcomes of a new curriculum on interproximal oral prophylaxis for dental students. PLoS ONE, Public Library of Science, 2018. 〈hal-01911954〉
  • Denis Bourgeois, Claude Dussart, Ina Saliasi, Laurent Laforest, Paul Tramini, et al.. Observance of Sterilization Protocol Guideline Procedures of Critical Instruments for Preventing Iatrogenic Transmission of Creutzfeldt-Jakob Disease in Dental Practice in France, 2017. International Journal of Environmental Research and Public Health, MDPI, 2018, 15 (5), pp.853 - 853. 〈10.3390/ijerph15050853〉. 〈hal-01819051〉
  • M. Belhassen, P. Demoly, E. Bloch-Morot, G. De Pouvourville, M. Ginoux, et al.. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy, Wiley, 2017, 72 (6), pp.948 - 958. 〈10.1111/all.13098〉. 〈hal-01798479〉
  • L. Laforest, M. Belhassen, G. Devouassoux, A. Didier, L. Letrilliart, et al.. L'adhésion thérapeutique dans l'asthme en France : revue générale. Revue Des Maladies Respiratoires, 2017, 〈10.1016/j.rmr.2016.03.013〉. 〈hal-01838966〉
  • L. Laforest, Manon Belhassen, Gilles Devouassoux, Alain Didier, Marine Ginoux, et al.. Long-Term Inhaled Corticosteroid Adherence in Asthma Patients with Short-Term Adherence. The Journal of Allergy and Clinical Immunology. In Practice, 2016, 4 (5), pp.890--899.e2. 〈10.1016/j.jaip.2016.07.008〉. 〈hal-01838972〉
  • Manon Belhassen, L. Laforest, Idlir Licaj, Éric Van Ganse. Early adherence to anti-glaucoma therapy: An observational study. Thérapie, EDP Sciences, 2016, 71 (5), pp.491-499. 〈10.1016/j.therap.2016.02.033〉. 〈hal-01838971〉
  • Manon Belhassen, Jacques De Blic, L. Laforest, Valérie Laigle, Céline Chanut-Vogel, et al.. Recurrent Wheezing in Infants: A Population-Based Study. Medicine, 2016, 95 (15), pp.e3404. 〈10.1097/MD.0000000000003404〉. 〈hal-01838969〉
  • Manon Belhassen, Carole Langlois, L. Laforest, Alexandra Lelia Dima, Marine Ginoux, et al.. Level of Asthma Controller Therapy Before Admission to the Hospital. The Journal of Allergy and Clinical Immunology. In Practice, 2016, 〈10.1016/j.jaip.2016.06.012〉. 〈hal-01838970〉
  • L. Laforest, Nicolas Roche, Gilles Devouassoux, Manon Belhassen, Christos Chouaid, et al.. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respiratory Medicine, 2016, 117, pp.33--39. 〈10.1016/j.rmed.2016.05.019〉. 〈hal-01838973〉
  • L. Laforest, É Van Ganse, G. Devouassoux, G. Chatté, C. Tamberou, et al.. Deliberate interruptions and changes of dose of inhaled corticosteroids by asthma patients: "a community pharmacy study". Revue Des Maladies Respiratoires, 2015, 32 (1), pp.8--17. 〈10.1016/j.rmr.2014.04.103〉. 〈hal-01838976〉
  • M. Belhassen, L. Levy-Bachelot, L. Laforest, M. Ginoux, E. Ganse. Identification of Osteoporosis & Chronic Inflammatory Rheumatic Disease In French Claims Data. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 2015, 18 (7), pp.A637. 〈10.1016/j.jval.2015.09.2264〉. 〈hal-01838977〉
  • Eric Van Ganse, Nathalie Texier, Alexandra L. Dima, L. Laforest, Montserrat Ferrer, et al.. Assessment of the safety of long-acting β2-agonists in routine asthma care: the ASTRO-LAB protocol. npj Primary Care Respiratory Medicine, 2015, 25, pp.15040. 〈10.1038/npjpcrm.2015.40〉. 〈hal-01838978〉
  • Manon Belhassen, Gérard De Pouvourville, Laurent Laforest, Jacques Brouard, Jacques De Blic, et al.. Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data study. BMC Pulmonary Medicine, BioMed Central, 2015, 15 (1), pp.51. 〈10.1186/s12890-015-0047-6〉. 〈inserm-01840484〉
  • Manon Belhassen, Gérard Pouvourville, L. Laforest, Jacques Brouard, Jacques Blic, et al.. Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data study. BMC Pulmonary Medicine, BioMed Central, 2015, 15, pp.51. 〈10.1186/s12890-015-0047-6〉. 〈hal-01838975〉
  • David Darmon, L. Laforest, Eric Van Ganse, Ferdinando Petrazzuoli, Chris Weel, et al.. Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice: a cross-sectional study based on French and Italian prescribing data. BMC Family Practice, BioMed Central, 2015, 16 (1), pp.14. 〈10.1186/s12875-015-0222-0〉. 〈hal-01838974〉
  • L. Laforest, Idlir Licaj, Gilles Devouassoux, Irene Eriksson, Pascal Caillet, et al.. Prescribed therapy for asthma: therapeutic ratios and outcomes. BMC Family Practice, BioMed Central, 2015, 16 (1), pp.49. 〈10.1186/s12875-015-0265-2〉. 〈hal-01838979〉
  • Gimena Hernández, Mónica Avila, Angels Pont, Olatz Garin, Jordi Alonso, et al.. Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies. Respiratory Research, 2014, 15, pp.83. 〈10.1186/1465-9921-15-83〉. 〈hal-01838981〉
  • Pascal Caillet, Susan B Jaglal, L. Laforest, Roland Chapurlat, Muriel Rabilloud, et al.. Impact of vitamin D supplementation on health-care use in a 25-hydroxyvitamin D-tested population in France: a population-based descriptive cohort study. Public health nutrition, 2014, pp.1--11. 〈10.1017/S136898001400038X〉. 〈hal-01838983〉
  • L. Laforest, Idlir Licaj, Gilles Devouassoux, Gérard Chatte, Jennifer Martin, et al.. Asthma drug ratios and exacerbations: claims data from universal health coverage systems. European Respiratory Journal, European Respiratory Society, 2014, 43 (5), pp.1378--1386. 〈10.1183/09031936.00100113〉. 〈hal-01838982〉
  • L. Laforest, Idlir Licaj, Gilles Devouassoux, Gérard Chatté, Manon Belhassen, et al.. Relative exposure to controller therapy and asthma exacerbations: a validation study in community pharmacies. Pharmacoepidemiology and Drug Safety, Wiley, 2014, pp.958 - 964. 〈10.1002/pds.3668〉. 〈hal-01838980〉
  • R Boussageon, L. Laforest, E Van Ganse. Are fixed combinations of inhaled corticosteroids and long-acting β2-agonists really harmless in asthmatics ?. Revue Des Maladies Respiratoires, 2012, 29 (9), 1169--1170; author reply 1170--1171. 〈10.1016/j.rmr.2012.09.009〉. 〈hal-01838984〉
  • L. Laforest, J. Martin, I. Licaj, G. Devouassoux, G. Chatte, et al.. Identification dans les bases de l'Assurance Maladie de facteurs associés aux grosses délivrances de bêtas agonistes inhalés à courte durée dans l'asthme. Revue des Maladies Respiratoires, Elsevier Masson, 2012, 16e Congres de Pneumologie de Langue Française, 29, Supplement 1, pp.A64. 〈10.1016/j.rmr.2011.10.199〉. 〈hal-01838985〉
  • M. Belhasse, I. Licaj, L. Laforest, E. Van Ganse. Étude observationnelle de la persistance aux traitements hypnotisants antiglaucomateux, Lyon, France. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2012, Ve Congrès International d'Épidémiologie "Épidémiologie et santé mondialisée", Bruxelles, 12-14 septembre 2012, 60, Supplement 2, pp.S143. 〈10.1016/j.respe.2012.06.373〉. 〈hal-01838986〉
  • L. Laforest, Laure Com-Ruelle, Mélanie Broquet, Gilles Devouassoux, Ericvan Ganse, et al.. Coût de l'asthme en France : Asthme de l'adulte.. Revue du Praticien (La), J B Bailliere et Fils, 2011, 61 (3), pp.336--338. 〈hal-01838987〉
  • L. Laforest, Francois Denis, Eric Van Ganse, Cecile Ritleng, Christel Saussier, et al.. Correlates of adherence to respiratory drugs in COPD patients. Primary Care Respiratory Journal: Journal of the General Practice Airways Group, 2010, 19 (2), pp.148--154. 〈10.4104/pcrj.2010.00004〉. 〈hal-01838988〉
  • Gaëlle Desamericq, Anne Revol, L. Laforest, Geneviève Chamba, Gisèle Bauguil, et al.. Migraine or headache management: a pharmacy survey. Thérapie, EDP Sciences, 2009, 64 (6), pp.395--403. 〈10.2515/therapie/2009057〉. 〈hal-01838991〉
  • L. Laforest, Eric Van Ganse, Cécile Ritleng, Gaelle Desamericq, Laurent Letrilliart, et al.. Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey. BMC Public Health, BioMed Central, 2009, 9, pp.337. 〈10.1186/1471-2458-9-337〉. 〈hal-01838992〉
  • L. Laforest, Thierry Souchet, Philippe Moulin, Cécile Ritleng, Gaëlle Desamericq, et al.. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2009, 102 (1), pp.43--50. 〈10.1016/j.acvd.2008.06.021〉. 〈hal-01838989〉
  • L. Laforest, Philippe Moulin, Thierry Souchet, Cécile Ritleng, Gaëlle Desamericq, et al.. Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy. Atherosclerosis, 2008, 199 (2), pp.368--377. 〈10.1016/j.atherosclerosis.2007.11.033〉. 〈hal-01838993〉
  • G. Devouassoux, A. Pachot, L. Laforest, J. Diasparra, N. Freymond, et al.. Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma. Allergy, 2008, 63 (1), pp.125--131. 〈10.1111/j.1398-9995.2007.01558.x〉. 〈hal-01838995〉
  • L. Laforest, Laure Com-Ruelle, Gilles Devouassoux, Christophe Pison, Eric Van Ganse, et al.. Enjeux économiques de l'asthme sévère : Asthme réfractaire : Des progrès diagnostiques et thérapeutiques.. La Presse Médicale, Elsevier Masson, 2008, 37 (1), pp.117--128. 〈hal-01838996〉
  • L. Laforest, Laure Com-Ruelle, Gilles Devouassoux, Christophe Pison, Eric Van Ganse. Economic aspects of severe asthma. La Presse Médicale, Elsevier Masson, 2008, 37 (1 Pt 2), pp.117--128. 〈10.1016/j.lpm.2007.06.019〉. 〈hal-01838994〉
  • Eric Van Ganse, L. Laforest, Thomas Burke, Hemant Phatak, Thierry Souchet. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Clinical Therapeutics, Elsevier, 2007, 29 (8), pp.1671--1681. 〈10.1016/j.clinthera.2007.08.003〉. 〈hal-01838998〉
  • L. Laforest, Philippe Moulin, Marie-Sophie Schwalm, Philippe Le Jeunne, Stephanie Chretin, et al.. Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugs. Nutrition, metabolism, and cardiovascular diseases: NMCD, 2007, 17 (9), pp.657--665. 〈10.1016/j.numecd.2006.07.012〉. 〈hal-01838997〉
  • Eric Van Ganse, L. Laforest, Gilles Devouassoux, Nathalie Freymond, Ahmed Arkhis, et al.. Projet d'éducation du patient asthmatique et proposition d'une méthode d'évaluation.. Pédagogie médicale, EDP sciences, 2007, 8 (1), pp.30--43. 〈hal-01839000〉
  • L. Laforest, Eric Van Ganse, Gilles Devouassoux, Jean Bousquet, Stephanie Chretin, et al.. Influence of patients' characteristics and disease management on asthma control. Journal of Allergy and Clinical Immunology, Elsevier, 2006, 117 (6), pp.1404--1410. 〈10.1016/j.jaci.2006.03.007〉. 〈hal-01839001〉
  • B. Fantino, N. Voirin, L. Laforest, F. Fantino, S. Chretin, et al.. Primary care physicians` behaviors towards risk of iatrogenesis in elderly patients. European Journal of Clinical Pharmacology, Springer Verlag, 2006, 62, pp.563-570. 〈hal-00427956〉
  • Eric Van Ganse, L. Laforest, Evo Alemao, Glenn Davies, Stephen Gutkin, et al.. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study. Current Medical Research and Opinion, Taylor & Francis, 2005, 21 (9), pp.1389--1399. 〈10.1185/030079905X59139〉. 〈hal-01839003〉
  • L. Laforest, Jean Bousquet, Françoise Neukirch, Michel Aubier, Guilhem Pietri, et al.. Influence of sociodemographic factors on quality of life during pollen season in seasonal allergic rhinitis patients. Annals of Allergy, Asthma and Immunology, Elsevier, 2005, 95 (1), pp.26--32. 〈10.1016/S1081-1206(10)61184-2〉. 〈hal-01839002〉
  • P Lemoine, A Sassolas, C Lestra, L. Laforest, G Chamba. Is there an interaction between sleep-disordered breathing, depression and apolipoprotein E phenotype ?. L'Encéphale, Elsevier Masson, 2004, 30 (4), pp.360--362. 〈hal-01839004〉
  • L. Laforest, Donald Yin, Vasilisa Sazonov Kocevar, Yves Pacheco, Neville Dickson, et al.. Association between asthma control in children and loss of workdays by caregivers. Annals of Allergy, Asthma and Immunology, Elsevier, 2004, 93 (3), pp.265--271. 〈hal-01839005〉
  • Annie J Sasco, L. Laforest, Véronique Benhaïm-Luzon, Martine Poncet, Ruth E Little. Smoking and its correlates among preadolescent children in France. Preventive Medicine, Elsevier, 2002, 34 (2), pp.226--234. 〈10.1006/pmed.2001.0980〉. 〈hal-01839006〉
  • Pascal Guénel, L. Laforest, Diane Cyr, Joëlle Févotte, Svend Sabroe, et al.. Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France. Cancer Causes and Control, Springer Verlag, 2001, 12 (5), pp.451--459. 〈https://link.springer.com/article/10.1023%2FA%3A1011271420974〉. 〈10.1023/A:1011271420974〉. 〈hal-01839007〉
  • L. Laforest, H Wikman, S Benhamou, S T Saarikoski, C Bouchardy, et al.. CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. European Journal of Cancer, Elsevier, 2000, 36 (14), pp.1825--1832. 〈hal-01839009〉
  • L. Laforest, D Luce, P Goldberg, D Bégin, M Gérin, et al.. Laryngeal and hypopharyngeal cancers and occupational exposure to formaldehyde and various dusts: a case-control study in France. Occupational and Environmental Medicine, BMJ Publishing Group, 2000, 57 (11), pp.767--773. 〈hal-01839010〉
  • C Chapron, L. Laforest, Y Ansquer, A Fauconnier, B Fernandez, et al.. Hysterectomy techniques used for benign pathologies: results of a French multicentre study. Human Reproduction, Oxford University Press (OUP), 1999, 14 (10), pp.2464--2470. 〈hal-01839011〉
  • L. Laforest, M. C. Annino, A. Alluard, D. Precausta, F. Wiele, et al.. Epidemiologic study of lead contamination of children of occupationally exposed parents. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 1999, 47 (5), pp.433--441. 〈hal-01839012〉
  • Carmen Kreft-Jais, L. Laforest, Alain Bonnardeaux, Cécile Dumont, Pierre-François Plouin, et al.. ACE inhibitors, cough, and genetics. Lancet, Elsevier, 1994, Originally published as Volume 1, Issue 8899, 343 (8899), pp.740--741. 〈10.1016/S0140-6736(94)91627-6〉. 〈hal-01839013〉